Primary hyperparathyroidism (PHPT) is a common endocrine disorder whic
h occurs most frequently in post-menopausal women and is characterized
by mild, stable, and often asymptomatic hypercalcaemia. Chronic parat
hyroid hormone excess stimulates bone remodelling by inducing producti
on by osteoblasts of soluble factors which stimulate both bone formati
on and osteoclastic bone resorption. Studies of bone mineral density (
BMD) in PHPT suggest that bone loss is accelerated, leading to osteope
nia, particularly at sites of cortical bone. Studies of fracture incid
ence in PHPT have produced conflicting results. Interventional studies
have demonstrated that both parathyroid adenomectomy and estrogen rep
lacement therapy increase BMD in patients with PHPT. Patients with PHP
T should undergo BMD measurement, and receive treatment designed to st
abilize bone mass if there is evidence of either osteopenia or acceler
ated bone loss.